Literature DB >> 15303792

Elephantiasis nostrum verrucosa of the abdomen: clinical results with tazarotene.

Jason Boyd1, Steven Sloan, Jeffrey Meffert.   

Abstract

Elephantiasis nostras verrucosa represents an uncommon yet distinct clinical entity resulting from chronic lymphedema of an extremity or body region. Characterized by profound non-pitting edema with cobblestone-like papules, plaques, and nodules, it typically occurs secondary to infections, surgeries, tumor obstruction, radiation, congestive heart failure, and obesity. This progressively deformative disorder has been treated with various medical and surgical measures. In the following case report, the history, clinical, and pathologic appearance of elephantiasis nostras verrucosa are discussed, as well as newer treatment options.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15303792

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  6 in total

1.  Elephantiasis nostras verrucosa of the pannus.

Authors:  Samuel Clark Berngard; Vignesh Narayanan
Journal:  J Gen Intern Med       Date:  2011-02-15       Impact factor: 5.128

2.  Elephantiasis nostras verrucosa: swelling with verrucose appearance of lower limbs.

Authors:  Fang-Yih Liaw; Ching-Fu Huang; Yu-Cheng Wu; Bai-Yao Wu
Journal:  Can Fam Physician       Date:  2012-10       Impact factor: 3.275

3.  A case of elephantiasis nostras verrucosa.

Authors:  Yun-Seok Yang; Jae-Jun Ahn; Sik Haw; Min-Kyung Shin; Choong-Rim Haw
Journal:  Ann Dermatol       Date:  2009-08-31       Impact factor: 1.444

4.  Bowenoid papulosis of the genitalia successfully treated with topical tazarotene: a report of two cases.

Authors:  Veeranna Shastry; Jayadev Betkerur
Journal:  Indian J Dermatol       Date:  2009-07       Impact factor: 1.494

5.  Elephantiasis nostras verrucosa: successful surgical treatment in a gross deformity.

Authors:  Purificación Gacto-Sánchez; P Fernandez-Ortega; J J Pereyra-Rodríguez
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

6.  Obesity-associated abdominal elephantiasis.

Authors:  Ritesh Kohli; Vivian Argento; Yaw Amoateng-Adjepong
Journal:  Case Rep Med       Date:  2013-03-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.